EP1651658 - NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST SODIUM-DEPENDANT TRANSPORTER [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 10.07.2020 Database last updated on 29.03.2025 | Most recent event Tooltip | 10.07.2020 | Patent maintained (B2 publication) | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states Mitsubishi Tanabe Pharma Corporation 3-2-10, Dosho-machi Chuo-ku, Osaka-shi Osaka 541-8505 / JP | [2016/06] |
Former [2013/03] | For all designated states Mitsubishi Tanabe Pharma Corporation 2-6-18, Kitahama Chuo-ku Osaka-shi Osaka 541-8505 / JP | ||
Former [2007/49] | For all designated states Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi Osaka 541-8505 / JP | ||
Former [2006/18] | For all designated states TANABE SEIYAKU CO., LTD. 2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505 / JP | Inventor(s) | 01 /
NOMURA, Sumihiro@c/o Mitsubishi Tanabe Pharma Corporation 2-6-18,Kitahama, Chuo-ku, Osaka-shi Osaka 541-8505 / JP | 02 /
KAWANISHI, Eiji@c/o Mitsubishi Tanabe Pharma Corporation 2-6-18,Kitahama, Chuo-ku, Osaka-shi Osaka 541-8505 / JP | 03 /
UETA, Kiichiro@c/o Mitsubishi Tanabe Pharma Corporation 2-6-18,Kitahama, Chuo-ku, Osaka-shi Osaka 541-8505 / JP | [2013/02] |
Former [2006/18] | 01 /
NOMURA, Sumihiro c/o TANABE SEIYAKU CO., LTD 2-10, Dosho-machi 3-chome,Chuo-ku, Osaka-shi Osaka 541-8505 / JP | ||
02 /
KAWANISHI, Eiji c/o TANABE SEIYAKU CO., LTD 2-10, Dosho-machi 3-chome, Chuo-ku, Osaka-shi Osaka 541-8505 / JP | |||
03 /
UETA, Kiichiro c/o TANABE SEIYAKU CO., LTD 2-10, Dosho-machi 3-chome, Chuo-ku, Osaka-shi Osaka 541-8505 / JP | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2020/33] |
Former [2013/03] | Vossius & Partner Siebertstrasse 4 81675 München / DE | ||
Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
Former [2006/18] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 04771314.4 | 30.07.2004 | [2006/18] | WO2004JP11312 | Priority number, date | US20030491534P | 01.08.2003 Original published format: US 491534 P | [2006/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005012326 | Date: | 10.02.2005 | Language: | EN | [2005/06] | Type: | A1 Application with search report | No.: | EP1651658 | Date: | 03.05.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.02.2005 takes the place of the publication of the European patent application. | [2006/18] | Type: | B1 Patent specification | No.: | EP1651658 | Date: | 16.01.2013 | Language: | EN | [2013/03] | Type: | B2 New European patent specification | No.: | EP1651658 | Date: | 12.08.2020 | Language: | EN | [2020/33] | Search report(s) | International search report - published on: | EP | 10.02.2005 | Classification | IPC: | C07H19/06 | [2006/18] | CPC: |
C07H19/048 (EP,CN,US);
C07H19/06 (EP,KR,US);
C07D409/10 (EP,CN,US);
A61K45/06 (EP,US);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P27/02 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P5/48 (EP);
A61P5/50 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07D405/04 (EP,CN,US);
C07D405/10 (CN);
C07D407/10 (CN);
C07D409/04 (EP,CN,US);
C07D409/14 (CN);
C07D417/10 (CN);
C07D417/14 (CN);
C07D495/04 (CN);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2020/33] |
Former [2006/18] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | HR | 23.02.2006 | LT | 23.02.2006 | LV | 23.02.2006 | Title | German: | NEUE VERBINDUNGEN MIT INHIBIERENDER AKTIVITÄT GEGENÜBER NATRIUMABHÄNGIGEN GLUKOSETRANSPORTER | [2006/18] | English: | NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST SODIUM-DEPENDANT TRANSPORTER | [2006/18] | French: | NOUVEAUX COMPOSES POSSEDANT UNE ACTIVITE INHIBITRICE DIRIGEE CONTRE LE TRANSPORTEUR DEPENDANT DU SODIUM | [2006/18] | Entry into regional phase | 23.02.2006 | National basic fee paid | 23.02.2006 | Designation fee(s) paid | 23.02.2006 | Examination fee paid | Examination procedure | 27.05.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.02.2006 | Examination requested [2006/18] | 19.04.2011 | Amendment by applicant (claims and/or description) | 20.10.2011 | Despatch of a communication from the examining division (Time limit: M04) | 19.12.2011 | Reply to a communication from the examining division | 10.02.2012 | Despatch of a communication from the examining division (Time limit: M04) | 08.06.2012 | Reply to a communication from the examining division | 20.07.2012 | Communication of intention to grant the patent | 30.11.2012 | Fee for grant paid | 30.11.2012 | Fee for publishing/printing paid | 09.12.2019 | Observations by third parties | Divisional application(s) | EP12176099.5 / EP2514756 | EP14194507.1 / EP2896397 | EP17173376.9 / EP3251679 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.10.2011 | Opposition(s) | Opponent(s) | 01
16.10.2013
21.10.2013
ADMISSIBLE Galenicum Health S.L. Avenida Diagonal 123 floor 11 08005 Barcelona / ES Opponent's representative Galenicum Health S.L.U. Avenida Diagonal 123, Floor 11 08005 Barcelona / ES | [N/P] |
Former [2015/10] | |||
Opponent(s) | 01
16.10.2013
21.10.2013
ADMISSIBLE Galenicum Health S.L. Avenida Diagonal 123 floor 11 08005 Barcelona / ES Opponent's representative Galenicum Health S.L. Avenida Diagonal 123, Floor 11 08005 Barcelona / ES | ||
Former [2013/48] | |||
Opponent(s) | 01
16.10.2013
21.10.2013
ADMISSIBLE Galenicum Health S.L. Avenida Diagonal 123 floor 11 08005 Barcelona / ES Opponent's representative Torrejón-Nieto, Javier Galenicum Health S.L. Intellectual Property Avenida Diagonal 123, floor 11 08005 Barcelona / ES | 20.11.2013 | Invitation to proprietor to file observations on the notice of opposition | 27.05.2014 | Reply of patent proprietor to notice(s) of opposition | 03.11.2015 | Date of oral proceedings | 07.12.2015 | Despatch of interlocutory decision in opposition | 07.12.2015 | Despatch of minutes of oral proceedings | 12.12.2019 | Legal effect of interlocutory decision in opposition | 26.03.2020 | Despatch of communication that the patent will be maintained as amended | 03.07.2020 | Fee for printing new specification paid | Appeal following opposition | 20.01.2016 | Appeal received No. T0184/16 | 15.04.2016 | Statement of grounds filed | 12.12.2019 | Result of appeal procedure: appeal of the opponent was rejected | 12.12.2019 | Date of oral proceedings | 10.01.2020 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 28.07.2006 | Renewal fee patent year 03 | 31.07.2007 | Renewal fee patent year 04 | 31.07.2008 | Renewal fee patent year 05 | 27.07.2009 | Renewal fee patent year 06 | 26.07.2010 | Renewal fee patent year 07 | 22.07.2011 | Renewal fee patent year 08 | 24.07.2012 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]GB2359554 (KOTOBUKI PHARMACEUTICAL COMPAN [JP]) [Y] 1-28 * the whole document *; | [Y]US6562791 (MAURYA RAKESH [IN], et al) [Y] 1-28* the whole document *; | [Y]US2003114390 (WASHBURN WILLIAM N [US], et al) [Y] 1-28 * the whole document *; | [E]WO2004080990 (YAMANOUCHI PHARMA CO LTD [JP], et al) [E] 1-28 * the whole document *; | [X] - AHMAD R ET AL, "SYNTHESIS AND STRUCTURE DETERMINATION OF SOME OXADIAZOLE-2-THIONE AND TRIAZOLE-3-THIONE GALACTOSIDES", NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS, MARCEL DEKKER, ANN HARBOR, MI, US, (2001), vol. 20, no. 9, ISSN 1525-7770, pages 1671 - 1682, XP009039308 [X] 1-6,8,18,25,26 * compounds 5A-5C,6A-6C * DOI: http://dx.doi.org/10.1081/NCN-100105903 | [X] - ZAMANI, KHOSROW ET AL, "Synthesis and structure determination of some new N-glycosides of 4,5-disubstituted-1,2,4-triazole-3-thiones", JOURNAL OF THE CHINESE CHEMICAL SOCIETY (TAIPEI, TAIWAN) , 49(6), 1041-1044 CODEN: JCCTAC; ISSN: 0009-4536, (2002), XP009039279 [X] 1-6,18,25,26 * compounds 6(A-C),7(A-C) * | [X] - MAATOOQ G T ET AL, "C-p-hydroxybenzoylglycoflavones from citrullus colocynthis", PHYTOCHEMISTRY, PERGAMON PRESS, GB, (199701), vol. 44, no. 1, ISSN 0031-9422, pages 187 - 190, XP004292916 [X] 1-5 * compound 4 * DOI: http://dx.doi.org/10.1016/S0031-9422(96)00465-7 | Opposition | WO2005012326 |